Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Song, Gea | Yang, Haiqiangb | Shen, Ningb | Pham, Phillipc | Brown, Breannac | Lin, Xiaoyangc | Hong, Yuzhuc | Sinu, Paulc | Cai, Jianfengb | Li, Xiaopengb | Leon, Michaelc | Gordon, Marcia N.d | Morgan, Davidd | Zhang, Saie | Cao, Chuanhaib; c; f; *
Affiliations: [a] Tianjin University of Traditional Chinese Medicine, Tianjin, P.R. China | [b] College of Arts and Science, University of South Florida, Tampa, FL, USA | [c] Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA | [d] Department of Translational Neuroscience, College of Medicine, Michigan State University, Grand Rapids, MI, USA | [e] Institution of Brain Trauma and Neurology Disease, Key Laboratory of Neurotrauma Repair of Tianjin, Tianjin, China | [f] College of Medicine, University of South Florida, Tampa, FL, USA
Correspondence: [*] Correspondence to: Chuanhai Cao, PhD, Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA. Tel.: +1 813 396 0742; E-mail: [email protected].
Abstract: Background:Aging is considered the most important risk factor for Alzheimer’s disease (AD). Recent research supports the theory that immunotherapy targeting the “oligomeric” forms of amyloid-β (Aβ) may halt the progression of AD. However, previous clinical trial of the vaccine against Aβ, called AN1792, was suspended due to cases of meningoencephalitis in patients. Objective:To develop a peptide sensitized dendritic cells (DCs) vaccine that would target oligomer Aβ and prevent an autoimmune response. Methods:Double transgenic APPswe/PS1ΔE9 (Tg) and C57BL/6J control mice were used in this study. Cytokine expression profile detection, characterization of antisera, brain GSK-3β, LC3 expression, and spatial working memory testing before and post-vaccination were obtained. Results:Epitope prediction indicated that E22W42 could generate 13 new T cell epitopes which can strengthen immunity in aged subjects and silence several T cell epitopes of the wild type Aβ. The silenced T cell epitope could help avoid the autoimmune response that was seen in some patients of the AN-1792 vaccine. The E22W42 not only helped sensitize bone marrow-derived DCs for the development of an oligomeric Aβ-specific antibody, but also delayed memory impairment in the APP/PS1 mouse model. Most importantly, this E22W42 peptide will not alter the DC’s natural immunomodulatory properties. Conclusion:The E22W42 vaccine is possibly safer for patients with impaired immune systems. Since there is increasing evidence that oligomeric form of Aβ are the toxic species to neurons, the E22W42 antibody’s specificity for these “oligomeric” Aβ species could provide the opportunity to produce some clinical benefits in AD subjects.
Keywords: Alzheimer’s disease, antibody, dendritic cells, T cell epitope, vaccine
DOI: 10.3233/JAD-200413
Journal: Journal of Alzheimer's Disease, vol. 77, no. 4, pp. 1639-1653, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]